
Diagnostic stewardship in clinical microbiology: current status and perspectives in Korea
Perspective Bosung Park, Mi-Na Kim Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Correspondence to Mi-Na Kim, E-mail: mnkim@amc.seoul.kr Ann Clin Microbiol 2025;28(2):9. https://doi.org/10.5145/ACM.2025.28.2.3Received on 8 May 2025, Revised on 22 May 2025, Accepted on 26 May 2025, Published on 16 June 2025.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Diagnostic stewardship aims to improve patient care quality by optimizing diagnostic test utilization, reducing unnecessary testing, and enhancing cost-effectiveness [1,2]. In Korea, diagnostic practices are in the early stages of developing a stewardship program. Although not exclusive to clinical microbiology, diagnostic stewardship programs (DSPs) have gained prominence owing to the global challenge of antimicrobial resistance, aligning with the expansion of antimicrobial stewardship programs (ASPs) [3]. This commentary examines the current status and perspectives of DSPs in
